Back to results
US 2022/0017607 A1Published application
Monoclonal antibodies against amyloid beta protein and uses thereof
AssigneesAbbVie Inc., AbbVie Deutschland GmbH & Co. KG
InventorsHeinz HILLEN, Stefan BARGHORN, Boris LABKOVSKY, Ulrich EBERT, Andreas STRIEBINGER, Patrick KELLER
Life of this patent
Estimating the term…
Abstract
The subject invention relates to monoclonal antibodies (e.g., 8F5 and 8C5) that may be used, for example, in the prevention, treatment, and diagnosis of Alzheimer's Disease or other neurodegenerative disorders.
Claims3
-6. (canceled)
A hybridoma having American Type Culture Collection designation number PTA-7238.
-56. (canceled)
Dependencies are inferred from the claim text.